CD4 and hepatocellular carcinoma: To date, the role of the two most prominent T cell subgroups in HCC development–CD4+ and CD8+ cells–causes scientific debate (Ringelhan et al., 2018; Ramadori et al., 2022); this issue arises from the fact that these cells are active throughout the disease timespan, possibly orchestrating different tissue responses that are disease stage-dependent.